NeuroRehabilitationxx(20xx)x–xx 1
DOI:10.3233/NRE-192714
IOSPress
A computer-based cognitive training in mild
cognitive impairment in parkinson’s disease
f
SaraBerninia,∗ ,AnnaAllonib,SilviaPanzarasab,MartaPicasciaa,SilvanaQuaglinib,Cristina
o
Tassorellic andElenaSinforiania
aNeuropsychology/Alzheimer’sDiseaseAssessmentUnit,IRCCSMondinoFoundation,Pavia,Italy
o
bDepartmentofElectrical,ComputerandBiomedicalEngineering,UniversityofPavia,Pavia,Italy
cDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy; Neurorehabilitation Unit,
IRCCSMondinoFoundation,Pavia,Italy r
P
d
Abstract.
BACKGROUND: There is no successful pharmacologicael treatment for cognitive impairment in Parkinson’s Disease,
thereforetreatmentscapableofslowingdowntheprogressionofcognitivedysfunctionareneeded.
OBJECTIVE:Toevaluatetheeffectivenessofacognitivetraining,supportedbytheCoRecomputerizedtool,inpatients
withParkinson’sDiseaseMildCognitiveImpairmentt.
METHODS:Thisisaprospective,open-unblindced,randomized,controlledstudy.Afterbaselinecognitiveassessment(T0),
enrolledpatientswererandomizedtoreceivemotorrehabilitationpluscognitiveintervention(G1)ormotorrehabilitation
only(G2).Follow-upassessmentswerescheduled4weeks(T1)and6monthsafter(T2).Globalcognitivefunctioningscores
e
(MOCAandMMSE)wereconsideredasprimaryoutcome.OutcomemeasuresatT0,T1andT2werecomparedwithin-
andbetween-groups.ApercentagechangescorebetweenT0andnextassessmentswascalculatedtoidentifypatientswho
improved,remainstableorworserned.
RESULTS:DifferentlyfromG2,G1showedamedium/largeeffectsizeimprovementinprimary(MoCA)andsecondary
r
outcome,bothbetweenT0andT1andT0andT2.Moreover,withinG1,mostpatientsimprovedtheircognitivestatecompared
tothebaseline. o
CONCLUSIONS:PatientstrainedwithCoReshowedabetterevolutionofcognitivedecline,whileuntreatedpatientstended
togetworseovertime.
C
Keywords:Cognitivetraining,executivedysfunctions,parkinson’sdisease,randomizedcontrolledtrial
1. Introduction ducedalsoinParkinson’sDisease(PD),similarlyto
whathappenedinAlzheimer’sDementia(AD)(Cavi-
Mild Cognitive Impairment (MCI) is used to nessetal.,2007;Litvanetal.,2012).
describe cognitive deficits that appear in the early At present, there is no successful pharmacologi-
stage of the neurodegenerative diseases and repre- caltreatmentforcognitiveimpairmentinPD(Emre,
sents a risk factor for the development of dementia Ford, Bilgic¸, & Uc¸, 2014; Orgeta et al., 2015). An
(Petersenetal.,1999).TheMCIconstructwasintro- extensive literature supports the beneficial effects
of cognitive training (CT) in healthy elder peo-
∗Addressforcorrespondence:SaraBernini,PsyD,PhD,Neu-
ple (Lampit, Hallock, & Valenzuela, 2014), in MCI
ropsychology/Alzheimer’s Disease Assessment Unit, IRCCS
and AD (Andrieu, Coley, Lovestone, Aisen, & Vel-
Mondino Foundation, Via Mondino 2, Pavia, 27100, Italy.
las, 2015; Coyle, Traynor, & Solowij, 2015; Rojas
Tel.: +39 0382380290; Fax: +39 0382380206; E-mail: sara.
bernini@mondino.it. et al., 2013). In the case of PD, evidence in favor
ISSN1053-8135/19/$35.00©2019–IOSPressandtheauthors.Allrightsreserved
2 S.Berninietal./CognitivetraininginParkinson’Sdisease
of the effectiveness of CT, using either computers approach since, for the advantages of the computer
orin-personinterventions,isstillpoor.Asystematic supportexplainedabove,wegaveforgrantedthenon-
reviewandmeta-analysis(Leungetal.,2015)iden- inferiorityofacomputerizedrehabilitationprogram
tifiedonly7RandomizedControlledTrials(RCTs). vsatraditionalone.
Thoughthesestudiesprovidedevidenceontheeffec-
tiveness of CT on cognition in PD patients, they
were based on small sample sizes and on different 2. Materialsandmethods
modalities of CT. Therefore, larger RCTs or fur-
ther confirmatory studies are necessary to examine 2.1. Participantsandmeasures f
the usability and usefulness of CT programs as a
o
treatment for cognitive decline in PD. Moreover, it InpatientswithidiopathicPDwererecruitedfrom
is currently unknown whether CT affects cognition theNeurorehabilitationUnitoftheIRCCSMondino
o
on long term in PD, due to the lack of longitudinal Foundation.Inclusioncriteriawere:
studies. Walton and colleagues (Walton, Naismith,
– diagnosis of idiopathic PD according to
Lampit,Mowszowski,&Lewis,2017)suggestedtwo r
UKPDBB criteria (Hughes, Daniel, Kilford, &
optionsaboutthepotentialoutcomesfromCTinPD:
Lees,199P 2)andHoehn&Yahrscale≤4(Hoehn
CTmaybrieflystabilizecognitivedecline,bydelay-
&Yahr,1967);
ing the downward trajectory, or it can attenuate the
– presenceofPD-MCIsingle-domain(executive)
rate of decline. Furthermore, it is not clear whether
or PD-MCI multiple-domain with executive
long-termeffectsofCTonboththeaboveoutcomes
d
involvement(Litvanetal.,2012);
aremorelikelyobtainedwithboostersessionsorwith
– agebetween50and85years;
long-termcontinuedCT.Inthisregard,onlyoneRCT
e – educationlevel≥5years.
(Petrellietal.,2015)providedafollow-upassessment
after1yearinPDpatientswithnormalcognitivepro- Exclusioncriteria:
file,inordertostudytheconversionprocesstotMCI.
The authors observed that patients who recceived a – pre-existingcognitiveimpairment(e.g.aphasia,
6-weeks CT program maintained their overall cog- neglect);
nitive functions, while those in theecontrol group – severedisturbancesinconsciousness;
showed a significant decline. Moreover, some stud- – severesensoryormotordisturbancesthatdonot
ies(Coyleetal.,2015;Waltonetal.,2017)suggested allowthepatienttocontrolthetrunkortomain-
r
thatcomputerizedCTmaybeefficaciousattheearly tain the sitting position; in particular patients
phases of PD, or where PrD-MCI is present, while withdisturbingrestingand/oractiontremor(cor-
it may not be beneficial at the Parkinson’s Disease responding to score 2–4 in the specific items
o
Dementiastage. of Unified Parkinson’s Disease Rating Scale
Computer-supportedCTdeliveryovercomessome (UPDRSIII)(Fahn,1987)wereexcluded;
limits of traditC ional paper-and-pencil approach. In – concomitant severe psychiatric or neurological
fact, computerized CT uses engaging motivational conditions;
cues and provides real-time feedback; task com- – patientswithDeepBrainStimulation.
plexity and response time demands may change
All the patients were treated with dopamine ago-
frequentlyduringandacrosssessions,inaccordance
nistsorL-DOPA;thetherapywasstablefor3months
withchangesinindividualperformance.Thisallows
and no variations were allowed during the training
avoiding over- or under-stimulation and providing
andfollow-upperiods.Thediseaseseveritywasrated
more training time in areas of relative weakness.
accordingtotheHoehn&YahrScaleandUPDRSIII.
Computer support also saves time for therapists in
The PD-MCI diagnosis was formulated on the
thepreparationoftheexercisesandallowstorecord
basis of a comprehensive neuropsychological eval-
allsessionparametersforfurtherstatistics.
uation (baseline cognitive assessment) according to
In the light of this background, we conducted a
theguidelines(levelIIcriteria)(Litvanetal.,2012);
prospective,open-unblindedRCTinordertoassess
the following standardized tests assessing different
the effectiveness of a computer-based CT (CoRe
domainswereadministered:
system)forthetrainingoflogicalandexecutivefunc-
tions in inpatients with PD-MCI. The study did not – global cognitive function: Mini-Mental State
includeacontrolgrouptreatedwithpaper-and-pencil Examination (MMSE) (Folstein, Folstein, &
S.Berninietal./CognitivetraininginParkinson’Sdisease 3
McHugh,1975)andMontrealMontrealOverall Disease Questionnaire (PDQ-8) (Jenkinson & Fitz-
Cognitive Assessment (MoCA) (Nasreddine patrick, 2007) at the baseline and six months after
etal.,2005); training.
– memory: verbal (Verbal Span, Digit Span) and Thesamplesizehasbeencalculatedonthebasisof
spatial (Corsi’s block-tapping test – CBTT) theglobalcognitivefunctioningmeasuredbyMoCA,
span(Spinnler,1987);verballong-termmemory which is more sensitive to executive dysfunction in
(Logical Memory Test immediate and delayed PD with respect to MMSE. We considered a basal
recall) (Carlesimo, Caltagirone, Gainotti, & value of MoCA equal to 24.9±3.5, as reported in
Nocentini, 1995), (Rey’s 15-word test imme- Huandcolleagues(Huetal.,2014)f.Weconsidered
diate and delayed recall) (Caffarra, Vezzadini, as a clinical significant improvement an increase of
o
Dieci, Zonato, & Venneri, 2002); spatial long- 3points.Usingastatisticalsignificancethresholdof
term memory (Rey Complex Figure delayed 0.05fortype-1errorandastudystatisticalpowerof
o
recall – RCF-dr) (Laiacona, Inzaghi, De Tanti, 80%, we obtained a sample size of 21 patients for
&Capitani,2000); group.
– logical-executive functions: non-verbal reason- ThestudywasarpprovedbythelocalEthicsCom-
ing(Raven’sMatrices1947–RM47)(Carlesimo mitteeandconductedinaccordancewiththeHelsinki
P
et al., 1995); categorical abstract reasoning Declaration of 1975; all the participants provided
(Weigl’s Sorting test) (Spinnler, 1987); frontal writtenInformedConsent.
functionality (Frontal Assessment Battery –
FAB)(Apollonioetal.,2005);semanticfluency 2.2. Studydesignandprocedures
d
(animals, fruits, car brands), phonological flu-
ency(FAS)(Carlesimoetal.,1995); Thisstudyisaprospective,open-unblindedRCT.
e
– attention: visual selective attention (Attentive All the PD patients recruited underwent base-
Matrices) (Carlesimo et al., 1995); simple line cognitive assessment (T0). Patients who met
speed processing and complex attention t(Trail the inclusion and exclusion criteria were enrolled
Making Test parts A - TMTA andcpart B and randomized to receive standard physical reha-
- TMTB) (Giovagnoli et al., 1996); selective bilitation plus cognitive intervention with CoRe
attention/susceptibility to interfeerence (Stroop (interventiongroup-G1)orstandardphysicalreha-
test)(Amatoetal.,2006); bilitation only (control group - G2). The standard
– visuospatialabilities:ReyComplexFigurecopy physicalrehabilitationwasthesameinthetwogroups
r
–RCF-copy(Laiaconaetal.,2000). in terms of frequency, duration and number of ses-
r sions. Standard physical rehabilitation comprises:
Thesamebatterywasalsousedatfollow-upvisits; cardiovascular warm-up activities, active and pas-
o
parallel versions were applied when available (ver- siveexercisestoimprovethejoints’rangeofmotion,
bal long-term memory tests), in order to avoid the stretching of the abdominal muscles, strengthen-
C
learningeffect.Allthetestscoreswerecorrectedfor ing of paravertebral muscles, postural changes, and
age,sex,andeducationandcomparedwiththevalues exercisesoperatingonbalanceandposturalcontrol.
availablefortheItalianpopulation. Neuropsychological evaluation and CoRe sessions
Atthebaseline,thepatients’functionalstatuswas wereadministeredexclusivelyduring“on”status.
assessed using Activities of Daily Living (ADL) Therandomizationlistwasgeneratedusingasim-
(Lawton, 1988), to evaluate basic everyday activ- ple randomization method with “random number
ities (the score ranges from 0 to 6, with higher generator”software.CoReprogramconsistedof12
scores corresponding to higher levels of indepen- individualsessions(3sessions/week)eachlasting45
dence) and Instrumental Activities of Daily Living minutes of computer-based logical-executive tasks.
(IADL) (Lawton, 1969), to evaluate more complex All the patients were evaluated at the end of the
activities (the score ranges from 0 to 8, with higher 4-weekstraining(T1)todetectthepresenceofatrain-
scores corresponding to higher levels of indepen- ingeffect(T0vsT1)andsubsequentlyatsixmonths
dence).Scoreindicatespreservedfunctions. fromtheendofCT(T2)toassessthepersistenceof
Moreover, mood were assessed using the Beck thetraining-relatedimprovement(T1vsT2).Wewill
DepressionInventory(BDI)(Beck,Steer,&Brown, alsoevaluatethemedium-termimpactofCTonthe
2010)atthebaselineandatthefollow-upvisits,while evolutionofcognitivedecline(comparativechanges
qualityoflifewereassessedusing8-ItemParkinson’s observedatT2withrespecttoT0inthetwogroups).
4 S.Berninietal./CognitivetraininginParkinson’Sdisease
2.3. TheCoResystem 7. LOGICAL SEQUENCES: a sequence of
images is shown, the patient must select,
CoRe (acronym for Cognitive Rehabilitation) is amongseveraloptions,theonethatcompletes
an ontology-based software tool that allows several theseries(non-verbalreasoning,mentalprob-
degreesofpersonalizationandthepossibilitytogen- lemsolving,decisionmaking);
eratedifferentpatient-tailoredexercises.Thestimuli 8. LOGICAL ANALOGIES: a “textual propor-
databaseiscreatedstartingfromtheontology,which tion” is shown with one of the four elements
describeseveryentitytroughasetofattributesandits missing and named as X (ELEMENT#1 is
relationwithotherentities(adetaileddescriptionof related to ELEMENT#2 as fELEMENT#3 is
theontologycanbefoundinLeonardi,Panzarasa,& relatedtoX);thepatientmustidentifytherela-
o
Quaglini,2011).Thisontologyimprovesthevariety tion and select the right element among the
andthepersonalizationoftheexercises,whichplaya proposed options (logical reasoning, concep-
o
vitalroleinreducingtheriskofboredomandincreas- tualabstractionabilities);
ing the compliance. The exercises administered in 9. FIND THE ELEMENTS: a matrix of ran-
thisstudyarethefollowingonesinbracketsthespe- dom text erlements (letters or numbers) is
cific executive sub-abilities involved are described displayed,thepatientmustidentifyandselect
P
(foramoredetaileddescriptionseepreviouspapers the requested ones (sustained and selective
(Allonietal.,2017;Alloni,Quaglini,Panzarasa,Sin- attention,visuo-spatialscanning,speed);
foriani,&Bernini,2018): 10. FUNCTIONALPLANNING:thepatientmust
select, among the proposed options, the ele-
d
1. FIND THE CATEGORY: the patient must mentsneededtoperformtheactiondisplayed
choose, between three textual options, the (mentalplanning,decisionmaking).
e
belonging category of the three images 11. CoRe was previously tested on healthy vol-
displayed (categorical thinking, conceptual unteers with different education levels and
abstractionabilities); t differentdegreeoffamiliaritywithPC(Alloni
2. FIND THE INTRUDER: five wcords are etal.,2017).Moreover,preliminarydatafrom
displayed, four of which belong to the the trial described in this paper were used
same category, the patient muest identify the toverifytheoverallsystemfunctionalityand
“intruder”elementthatbelongstoadifferent usability(e.g.,intermsofcompletedsessions),
category (verbal-logical reasoning, cognitive aswellastoobtaininitialresultsonitseffec-
r
flexibility,problemsolving); tiveness(Allonietal.,2018).
3. UNSCRAMBLE TrHE SENTENCE: scram-
bled words are displayed; the patient must 2.4. Statisticalanalysis
o
select them in the right order to compose a
sensiblesentence(mentalandverbalplanning OurhypothesiswasthatsubjectsinG1hadahigher
C
andconceptualabstractionabilities); probability of maintaining or improving their cog-
4. UNSCRAMBLETHEIMAGES:thesameas nitive level than subjects in G2. The scores of the
above, the patient must put the scrambled neuropsychologicaltestswereconsideredasoutcome
imagesintherightordertoformashortstory measures. Particularly, the primary outcome mea-
(planningofactivities,problemsolving,tem- sures were the global cognitive functioning scores
poralsequencing,visualattention); (MoCA and MMSE), while the secondary outcome
5. IMAGE AND SOUND: an image (small or measuresweretheexecutivetestsscores.Moreover,
big) is displayed and a sound (with low or non-executive test scores were also considered, as
high volume) is played; the patient must explorative outcomes, to assess whether the treat-
evaluate whether size and volume match menteffectcouldbetransferredevenintountrained
(inhibitory control, multi-tasking, working- domains. The effects of the training measured at
memory,maintenanceofattentionovertime); T0,T1andT2werecomparedwithin-andbetween
6. WORD COUPLING: eight words are dis- groups. Considering the small sample size, normal-
played,thepatientmustassociatetheminfour ity tests cannot be expected to give reliable results,
couples, identifying the relations that exist so non-parametric tests are to be preferred. There-
betweenthestimuli(verbal-logicalreasoning fore,Friedman’sanalysisofvariancehasbeenused
basedonpreviousknowledge); to compare the data obtained in the three cognitive
S.Berninietal./CognitivetraininginParkinson’Sdisease 5
assessments, while Wilcoxon test was used to per- age71.18±7.04years,meaneducation9.06±4.51
formthegroup-groupevaluations(T0vsT1,T1vsT2, years)and18toG2(11M/7F,meanage69.33±7.72
T0vsT2).Aneffectssizeindex(Cohen’sd)wascalcu- years,meaneducation7.67±3.50years).WithinG1,
latedtomeasurethemagnitudeofthetreatmenteffect 6patientsdropped-outbecausetheyweredischarged
for each significant difference. Contingency tables from the hospital before the end of CT program,
wereusedtoinvestigatetheassociationbetweenthe therefore statistical analysis considered 17 patients
intervention and the improvement (Fisher’s exact in G1 and 18 in G2 (see CONSORT diagram in
test). Fig. 1). In G1 11/17 and in G2 10/18 patients pre-
InordertodetecttheimpactofCTonprimaryout- sented a prevalent rigid-akinetic fform, while 6/17
comes,forbothgroups,themeanpercentagechange and8/18respectivelyaprevalenttremorigenicform.
o
scores for MMSE and MoCA were calculated and Four patients (2 in G1 and 2 in G2) presented a
compared between the baseline and the next eval- moderatefreezing.Nopatientspresentedimpulsive-
o
uations (Wilcoxon test). Moreover, as suggested by compulsive disorders or hallucinations. Moreover,
Binettiandcolleagues(Binettietal.,2013)foreach patientswithexecutive-single-domainPD-MCIwere
patient, the percentage change of the two primary 2/17inG1and2/1r8inG2respectively,theremain-
outcomes at T1 and T2 with respect to the base- ingpatientspresentedmultiple-domainPD-MCIwith
P
line value at T0 were calculated, i.e. 100x(T1 score executiveinvolvement.
- T0 score)/(T0 score), and 100x(T2 score - T0 The demographic and clinical characteristics and
score)/(T0score).Patientswithapercentagechange the m ean neuropsychological scores at T0 are
equal to 0 were considered as being stable, those reported in Table 1; no baseline differences were
d
withapercentagechangegreaterthan0wereconsid- found between the two groups. Table 2 shows the
eredasimproved;alltheotherpatientsweredefined mean (SD) neuropsychological scores and clini-
e
as non-responders, as described also in Petrelli’s cal data at T1 and T2; Table 3 shows the results
study(Petrellietal.,2015).Thisallowedtoidentify (Wilcoxon test) of the intra-group and inter-group
and compare (Fisher’s Test) the number of pattients comparisonsoftheneuropsychologicalscoresatT0,
whoimproved,retainedorworsenedtheirccognitive T1,T2.Theresultsarepresentedwiththeindication
state in the two groups between T0 and T1 and T0 of the significance with correction for the compar-
andT2. e isonsatdifferenttimes(*)andformultipleendpoints
∗∗
When two groups are compared, the results are ( ).
commonlyconsideredsignificantforp-valueslower ComparisonbetweenT0andT1
r
than 0.05. However, since we also compared the –within-groupanalysis:
same variable at differenrt times, and performed a G1 showed statistically significant improvements
number of tests on multiple endpoint variables, we atMoCA,Rey’s15-wordtestimmediaterecall,Log-
o
adopted the FDR (false discovery rate) correction icalMemoryTestimmediaterecall,Weigl’sTestand
methoddescribedin(Benjamini&Yekutieli,2001). FAS, while G2 showed no statistically significant
C
We applied the correction both for the comparisons changescomparedtothebaselinescores.
atdifferenttimes,andforthethreetimemeasuresof –between-groupanalysis:
themultipleendpoints. G1 performed significantly better than G2 at
All statistical analyses were performed using R MoCA,Rey’s15-wordtestimmediaterecall,Logical
(https://www.r-project.org/). MemoryTestimmediaterecall,Weigl’sTest,TMTA,
RM47andStroopTesttimeinterference.
ComparisonbetweenT1andT2
3. Results –within-groupanalysis:
G1showedasignificantworseningatMoCAand
Seventy-sevenPDpatientswererecruited.Outof FAS.
them, 36 were excluded because they did not meet G2 showed significant worsening at MoCA and
the inclusion/exclusion criteria. The main reasons FASsimilarlytoG1,butalsoatMMSEandFAB.
forexclusionwereabsenceofcognitiveimpairment, –between-groupanalysis:–therewerenosignifi-
presenceofMCIwithoutexecutiveinvolvement,PD cantdifferencesinthetestscoresvariationsbetween
dementiaorDeepBrainStimulation. thegroups.
Among the 41 patients enrolled, 23 patients ComparisonbetweenT0andT2
were randomly assigned to G1 (7M/16F, mean –within-groupanalysis:
6 S.Berninietal./CognitivetraininginParkinson’Sdisease
f
o
o
r
P
d
e
t
c
e
r
r
o
C
Fig.1. CONSORTflowchartwiththefollow-upinformation.
G1showedstatisticallysignificantimprovementat The mean percent change in MMSE and MoCA
MoCA, Rey’s 15-word test immediate and delayed scores between T0 and T1 and between T0 and T2
recallandWeigl’sTest. werecalculatedforG1andG2(Table4).
G2 showed significant worsening at MoCA, RegardingMoCA,G1improvedbothbetweenT0
MMSEandFAB. andT1andbetweenT0andT2,whileG2worsened.
–between-groupanalysis: Regarding MMSE, G1 slightly improved, while G2
G1 performed significantly better than G2 at slightlyimprovedbetweenT0andT1butworsened
MoCA, Rey’s 15-word test immediate and delayed betweenT0andT2.
recall, Weigl’s Test, FAB, TMTA and Stroop Test In particular, there was no significant group dif-
timeinterferenceanderrorinterference. ference in the mean percentage change scores at
S.Berninietal./CognitivetraininginParkinson’Sdisease 7
Table1
MeanandstandarddeviationofdemographicdataandneuropsychologicalscoresatT0
Demographicdataand T0 (W)p
neuropsychologicalscores G1 G2
M(DS) M(DS)
PATIENTS(M/F) 17(6/11) 18(11/7) 0.11
AGE 71.18(7.04) 69.33(7.72) 0.36
SCHOOLATTENDANCE(years) 9.06(4.51) 7.67(3.50) 0.36
DISEASEDURATION(years) 7.18(3.19) 10.67(7.36) 0.15
HOEHN&YAHRSCALE 2.8(0.96) 2.9(0.47) 0.46
f
UPDRSIII 37.82(13.93) 36.50(12.82) 0.74
PDQ-8(SummaryIndex) 41.7(20.9) 40.9(21.2) 0.o51
BDI 3.1(1.7) 3.2(1.5) 0.33
ADL 5.5(0.2) 5.4(0.4) 0.36
IADL 7.1(1.2) 7.2(1.1) o0.79
MMSE 25.32(2.26) 25.35(2.68) 0.96
MoCA 20.82(3.34) 19.17(3.49) 0.16
DIGITSPAN 4.32(0.32) 4.13r(0.90) 0.70
CBTT 3.74(1.12) 3.81(0.82) 0.96
P
VERBALSPAN 3.62(0.55) 3.42(0.48) 0.32
REY’S15WORDTEST-ir 33.99(7.05) 29.33(7.39) 0.06
REY’S15WORDTEST—dr 6.25(2.89) 5.86(2.04) 0.49
LOGICALMEMORYTEST-ir 4.06(2.61) 4.66(2.41) 0.60
LOGICALMEMORYTEST-dr 4.62(2.67) 5.39(2.19) 0.50
d
RM47 23.32(5.95) 21.02(4.70) 0.33
WEIGL’STEST 6.41(2.77) 5.85(2.06) 0.57
FAB 13.21(1.86) 12.58(2.06) 0.27
e
TMTA 144.47(61.51) 121.71(53.90) 0.20
TMTB 236.71(104.09) 216.94(119.21) 0.61
ATTENTIVEMATRICES 39.93(11.77) 38.95(9.07) 0.70
t
STROOPTESTTIME 28.26(19.95) 21.52(11.07) 0.43
STROOPTESTERROR c 8.56(6.55) 5.88(5.05) 0.28
PHONOLOGICALFLUENCY(FAS) 27.25(10.66) 24.38(9.30) 0.39
SEMANTICFLUENCY 32.71(5.79) 29.15(8.61) 0.06
e
RCFcopy 26.54(8.11) 24.01(9.00) 0.43
RCF-dr 13.54(5.61) 10.51(6.49) 0.15
Abbreviations:rG1 = Intervention Group; G2 = Control Group; M = mean; SD = standard
deviation;(W)p=Wilcoxontestpvaluesforinter-groupcomparisons;UPDRSIII=Unified
Parkinson’rsDiseaseRatingScaleIII;PDQ-8=8-ItemParkinson’sDiseaseQuestionnaire;BDI
=BeckDepressionInventory;ADL=ActivitiesofDailyLiving;IADL=InstrumentalActivities
o
ofDailyLiving;MMSE=Mini-MentalStateExamination;MoCA=MontrealMontrealOverall
CognitiveAssessment;CBTT=Corsi’sblock-tappingtest;ir=immediaterecall;dr=delayed
Crecall;RM47=Raven’sMatrices1947;FAB=FrontalAssessmentBattery;TMTAandB=
TrailMakingTestpartsAandB;RCF=ReyComplexFigure.
MMSEbothbetweenT0andT1(p=0.5)andT0and ationbetweengroups(G1andG2)andperformance
T2 (although at the limit of significance: p 0.058); (improved,stableandworsened).
whiletherewassignificantgroupdifferenceatMoCA Nosignificantdifferencebetweentheperformance
bothbetweenT0andT1(p<0.0001)andT0andT2 of the two groups at MMSE was observed between
(p<0.0001),whereG1performedsignificantlybetter T0 and T1 (F p-value=0.838), while between T0
thanG2. and T2 there was significant group difference (F p-
Contingency tables (Table 5) display for each value=0.043),sinceinG1mostpatientsimprovedor
group the number and percentage of patients that remainedstable,whileinG2mostpatientsworsened.
improved, remained stable or worsened respec- Moreover, at MoCA there was a significant differ-
tively in MoCA and MMSE between the baseline ence in the two groups both between T0 and T1 (F
and the next evaluations; the Fisher’s Exact test p-value<0.0001)andbetweenT0andT2(Fp-value
p-values show whether there is a significant associ- <0.0001),sinceinG1mostpatientsimprovedwhile
8 S.Berninietal./CognitivetraininginParkinson’Sdisease
Table2
MeanandstandarddeviationofclinicaldataandneuropsychologicalscoresatT1andT2
Clinicaldataand T1 T2
neuropsychologicalscores G1M(DS) G2M(DS) G1M(DS) G2M(DS)
UPDRSIII 29.05(10.18) 28.3(11.71)
PDQ-8(SummaryIndex) 39.7(21.4) 39.2(21.6)
BDI 3.1(1.5) 3.1(1.4) 3.0(1.5) 3.1(1.6)
MMSE 25.51(2.02) 25.38(2.09) 25.59(1.99) 24.49(2.08)
MoCA 23.52(2.78) 19.11(3.32) 22.58(2.95) 17.61(4.08)
DIGITSPAN 4.51(0.62) 4.11(0.47) 4.27(0.30) 3.79(0.90)
f
CBTT 4.16(0.82) 3.77(7.39) 3.98(0.60) 3.56(0.58)
VERBALSPAN 3.85(0.62) 3.55(0.78) 3.69(0.49) o 3.37(0.58)
REY’S15WORDTEST-ir 39.54(9.06) 29.71(6.24) 37.84(9.03) 28.55(5.27)
REY’S15WORDTEST-dr 7.68(2.32) 5.24(2.05) 7.90(1.68) 5.06(2.09)
LOGICALMEMORYTEST-ir 5.35(2.04) 4.37(4.70) 4.72o(1.56) 4.37(1.98)
LOGICALMEMORYTEST-dr 4.52(1.38) 5.81(1.52) 5.75(1.50) 5.29(1.69)
RM47 25.57(3.92) 20.45(4.44) 23.80(4.81) 19.22(6.21)
WEIGL’STEST 9.32(2.64) 6.15(2.44) r8.32(1.98) 5.62(2.29)
FAB 14.48(2.25) 12.35(1.68) 14.09(1.53) 11.13(1.37)
P
TMTA 108.82(58.33) 124.82(59.54) 121.94(53.21) 145.64(77.68)
TMTB 212.11(74.28) 213.94(112.53) 227.05(94.76) 182.70(122.70)
ATTENTIVEMATRICES 43.29(5.89) 39.90(7.97) 41.89(9.07) 38.48(8.64)
STROOPTESTTIME 19.66(13.13) 24.66 (11.44) 24.63(15.84) 29.40(14.50)
STROOPTESTERROR 5.16(4.20) 5.67(4.34) 5.64(4.55) 8.47(10.77)
d
PHONOLOGICALFLUENCY(FAS) 33.15(11.10) 24.87(7.67) 28.17(8.71) 23.43(7.24)
SEMANTICFLUENCY 32.88(4.58) 28.96(6.49) 33.64(5.72) 29.83(5.50)
RCFcopy 28.05(6.95) 24.84(8.82) 26.16(7.34) 23.76(8.20)
e
RCF-dr 15.91(4.39) 12.19(5.33) 14.54(5.54) 10.75(7.26)
Abbreviations:G1=InterventionGroup;G2=ControlGroup;ir=immediaterecall;dr=delayedrecall;M=mean;SD=standarddeviation;
UPDRSIII=UnifiedParkinson’sDiseaseRatingScaleIItI;PDQ-8=8-ItemParkinson’sDiseaseQuestionnaire;BDI=BeckDepression
Inventory;ADL=ActivitiesofDailyLiving;IADL=InstrumentalActivitiesofDailyLiving;MMSE=Mini-MentalStateExamination;
c
MoCA=MontrealMontrealOverallCognitiveAssessment;CBTT=Corsi’sblock-tappingtest;ir=immediaterecall;dr=delayedrecall;
RM47=Raven’sMatrices1947;FAB=FrontalAssessmentBattery;TMTAandB=TrailMakingTestpartsAandB;RCF=ReyComplex
Figure. e
in G2 most patients maintained their performance cognitiveperformancescoremeasuredbyMoCA(a
r
between T0 and T1 and worsened between T0 and primary outcome measure) and in many executive
T2. r tests (secondary outcome measures). Furthermore,
AsbytheUPDRSIII,bothgroupsshowedstatisti- inter-groupanalysisconfirmedthattheimprovement
o
callysignificantmotorimprovementbetweenT0and in G1 was statistically different from G2 in several
T1 (G1 p<0.04; G2 p<0.05), while there was no executiveandnon-executivetests.Sincethetraining
C
significantdifferenceinthescalevariationsbetween tasksdifferedfromthetestsusedduringtheneuropsy-
thegroupsatT1(Table1).Withregardtothemood, chological assessments and parallel test versions
therewasnosignificantgroupdifferenceinBDIscore wereused,whenavailable,onpost-assessment,these
betweenthebaselineandthefollow-upvisits.Nodif- resultsmayreflectlearningofappropriatestrategies
ferenceshavebeenreportedatPDQ-8bothatbaseline ratherthansimplepracticeeffects.
andaftersixmonthswithineachgroup. A follow-up evaluation was scheduled 6 months
aftertheendofthetraining,withtheaimofdetect-
4. Discussion ing(1)ifpost-trainingimprovementwasmaintained
over time and (2) how CT affects the evolution of
This prospective, open-unblinded RCT aimed to cognitive decline in medium-term. About the first
evaluate the effectiveness of a CT supported by a aim,comparingthepost-trainingassessmentwiththe
computerized tool (CoRe system) in PD-MCI. The last follow-up assessment, G1 behaved as G2 and
analysisoftheresultsallowstodrawseveralconsid- no post-training improvement was maintained six
erations. months later. We can conclude that the benefits of
Cognitiveinterventionhadpositiveeffectsimme- the training are evident immediately afterward but
diatelyaftertheendoftraining.G1patientsshoweda not at the six-month follow-up. The reason is prob-
medium/largeeffectsizeimprovementintheoverall ablyrelatedtothedurationofthetrainingprogram.
S.Berninietal./CognitivetraininginParkinson’Sdisease 9
Table3
Z-valuedifferencesofT0vsT1,T1vsT2andT0vsT2.Intra-groupcomparisons(Wilcoxonsigned-ranktest(W)andCohen’sdeffectsizes
(d))aswellasinter-groupcomparisonsusingtheWilcoxonsigned-ranktest(W)areshown.Underlinednumbersrepresentpositiveresults
(improvement),italicnumbersrepresentnegativeresults(worsening)
InterventionGroup(G1) ControlGroup(G2) Inter-g
Z (W)pIntra-g d Z (W)pIntra-g d Z (W)p
NpsTests(T0vsT1)
MMSE 0.43 0.661 0.21 0.836 0.40 0.684
MoCA 3.47 0.0005** 0.87 0.22 0.821 4.27 0.00001**
DIGITSPAN 1.13 0.258 0.19 0.850 f1.29 0.196
CBTT 1.41 0.158 0.26 0.792 1.33 0.181
o
VERBALSPAN 1.37 0.169 1.19 0.234 0 1.00
REY’S15WORDTEST-ir 3.42 0.0006** 0.68 1.18 0.237 3.32 0.0008**
REY’S15WORDTEST-dr 1.43 0.151 0.96 0.332 1.65 0.098
o
LOGICALMEM-ir 2.57 0.010* 0.55 0.35 0.724 2.66 0.007**
LOGICALMEM-dr 1.54 0.123 1.13 0.255 0.59 0.550
RCF-dr 1.80 0.071 1.71 0.087 0.52 0.6
r
RM47 2.30 0.021 1.21 0.225 2.49 0.012*
WEIGL’STEST 2.93 0.003* 1.07 0.98 P0.325 2.66 0.007**
FAB 2.17 0.029 0.52 0.601 2.17 0.029
TMTA 2.32 0.020 0.56 0.569 3.17 0.001**
TMTB 1.55 0.120 0.18 0.856 0.87 0.379
ATTENTIVEMATRICES 1.25 0.208 0.59 0.553 0.52 0.596
STROOPTIME 2.35 0.018 d1.67 0.093 3.11 0.001*
STROOPERROR 2.27 0.022 1.33 0.182 2.26 0.023
PHONFLUENCY(FAS) 2.65 0.007* 0.54 0.65 0.516 2.33 0.019
SEMANTICFLUENCY 0.09 0.923 e 1.05 0.293 0.64 0.516
RCFcopy 0.62 0.53 0.44 0.660 0.21 0.829
NpsTests(T1vsT2)
t
MMSE 0.53 0.596 3.62 0.0002** –0.42 1.83 0.066
MoCA 2.40 0.016* c –0.32 3.22 0.001** –0.40 1.09 0.274
DIGITSPAN 1.51 0.129 1.92 0.054 00.14 0.887
CBTT 0.83 0.40 1.33 0.182 0.22 0.821
e
VERBALSPAN 0.93 0.350 1.33 0.182 0 1.0
REY’S15WORDTEST-ir 1.72 0.084 1.33 0.182 0.54 0.582
REY’S15WORDTEST-dr 0.35 0.721 0.51 0.608 0.84 0.398
r
LOGICALMEM-ir 1.73 0.083 0.99 0.319 0.79 0.427
LOGICALMEM-dr r0.99 0.319 2.15 0.031 0.76 0.447
RCF-dr 1.61 0.106 1.23 0.217 0.21 0.829
RM47 o2.38 0.017 0.94 0.346 0.86 0.386
WEIGL’STEST 1.58 0.113 2.33 0.019 0.03 0.972
FAB 1.06 0.287 2.82 0.004** –0.79 1.31 0.189
TMTA C 1.32 0.187 2.09 0.036 0 1.0
TMTB 0.97 0.328 0.85 0.394 1.74 0.081
ATTENTIVEMATRICES 0.39 0.697 1.68 0.092 0.64 0.518
STROOPTIME 1.78 0.074 1.71 0.087 0.22 0.822
STROOPERROR 1.66 0.096 1.87 0.0612 0.29 0.768
PHON.FLUENCY(FAS) 2.63 0.008* –0.49 2.42 0.015* –0.19 1.61 0.107
SEMANTICFLUENCY 0.54 0.588 0.43 0.666 0.629 0.529
RCFcopy 1.03 0.299 1.37 0.168 0 1.0
NpsTests(T0vsT2)
MMSE 0 1.0 2.33 0.019* –0.35 1.87 0.060
MoCA 2.38 0.017* 0.71 3.22 0.001** –0.41 3.69 0.0002**
DIGITSPAN 0 1.0 2.15 0.031 2.13 0.032
CBTT 1.18 0.236 1.42 0.154 1.60 0.107
VERBALSPAN 0.44 0.656 0.18 0.850 0.72 0.468
REY’S15WORDTEST-ir 2.70 0.006* 0.47 0.97 0.329 2.70 0.006**
REY’S15WORDTEST-dr 2.40 0.016* 0.69 1.64 0.099 2.79 0.005**
LOGICALMEM-ir 1.18 0.236 1.18 0.234 1.45 0.145
LOGICALMEM-dr 1.18 0.234 0.31 0.756 1.24 0.214
RCF-dr 1.37 0.170 0.65 0.513 0.41 0.679
(continuednextpage)
10 S.Berninietal./CognitivetraininginParkinson’Sdisease
Table3
(Continued)
InterventionGroup(G1) ControlGroup(G2) Inter-g
Z (W)pIntra-g d Z (W)pIntra-g d Z (W)p
RM47 0.49 0.623 1.97 0.048 1.75 0.078
WEIGL’STEST 2.96 0.003* 0.79 0.40 0.684 3.15 0.001**
FAB 1.82 0.068 3.14 0.001** –0.82 3.38 0.0007**
TMTA 2.17 0.029 2.20 0.027 2.96 0.003**
TMTB 1.26 0.205 1.62 0.105 0.03 0.972
ATTENTIVEMATRICES 0.65 0.513 0.76 0.447 0.57 0.562
f
STROOPTIME 0.90 0.365 2.35 0.018 3.11 0.001**
STROOPERROR 0.56 0.573 2.55 0.010 o2.66 0.007**
PHON.FLUENCY(FAS) 0.94 0.343 0.88 0.378 1.38 0.164
SEMANTICFLUENCY 0.85 0.390 0.55 0.582 0.23 0.816
RCFcopy 0.85 0.393 0.64 0.522 o 0.16 0.868
Abbreviations: Nps=neuropsychological; ir=immediate recall; dr=delayed recall; MMSE=Mini-Mental State Examination;
MoCA=MontrealMontrealOverallCognitiveAssessment;CBTT=Corsi’sblock-tappingtestr;ir=immediaterecall;dr=delayedrecall;
RM47=Raven’sMatrices1947;FAB=FrontalAssessmentBattery;TMTAandB=TrailMakingTestpartsAandB;RCF=ReyComplex
Figure;Z=z-valuedifferencesbetweenT0vsT1orT1vsT2orT0vsT2intra-groupsandintePrgroups;(W)pintra-g=Wilcoxontestpvalues
forintra-groupcomparisons;(W)pinter-g=Wilcoxontestpvaluesforinter-groupcomparisons;d=Cohen’sdeffectsizeintra-groupswith
d=.2smalleffect,d=.5moderateeffect,d=.8largeeffect;p-valuesthatresultedstillsignificantaftercorrectionsforthecomparisonsat
differenttimes(*)orformultipleendpoints(**).
Table4 d
MeanpercentagechangescoresatMMSEandMoCAforG1andG2betweenT0andT1andbetweenT0andT2
T0vsT1 e T0vsT2
G1 G2 p G1 G2 P
MoCAM(SD) 17.18(12.09) –0.036(4.67) <0.001 9.96(13.57) –8.78(8.5) <0.0001
MMSEM(SD) 1.02(6.12) 0.54(6.63)t0.5(n.s.) 1.96(11.19) –3.02(5.16) 0.058(n.s.)
Abbreviations: G1=Intervention Group; G2=Controcl Group; p=values of statistical significance; M=mean; SD=standard deviation;
n.s.=notsignificant.
e
Table5
PerformanceatMMSEandMoCAinG1andG2betweenT0andT1andbetweenT0andT2
r
MoCA
rT0vsT1 T0vsT2
Improved Stable Worsened Improved Stable Worsened
o
G1 16(94.1%) 0 1(5.9%) 13(76.5%) 0 4(23.5%)
G2 3(16.7%) 10(55.5%) 5(27.8%) 1(5.5%) 3(16.7%) 14(77.8%)
Fp-values:<0.0001 Fp-values:<0.0001
C
MMSE
T0vsT1 T0vsT2
Improved Stable Worsened Improved Stable Worsened
G1 7(41.2%) 5(29.4%) 5(29.4%) 6(35.3%) 7(41.2%) 4(23.5%)
G2 6(33.3%) 6(33.3%) 6(33.3%) 2(11.1%) 4(22.2%) 12(66.7%)
Fp-values:notsignificant(0.838) Fp-values:=0.043
Abbreviations:G1=InterventionGroup;G2=ControlGroup;Fp-values=Fisher’sExacttestpvalues;M=mean;SD=standarddeviation;
n.s.=notsignificant.
Literaturesuggeststhattheexecutivefunctionsneed age the patient to continue the treatment at home
tobecontinuouslystimulatedovertimesincetraining (Allonietal.,2018).Tothisconcern,Waltonandcol-
hasastrongimpactintheshorttermbutnotproba- leagues(Waltonetal.,2017)highlightedthepossible
bly enough to maintain efficient functioning in the role of boosters or additional CT after completion
long term (Moro et al., 2015). A possible solution to maintain the CT benefit. Regarding the second
would be to increase the number of weekly sittings aim,boththeintra-andtheinter-groupcomparisons
during the period of treatment and then encour- showedthataftersevenmonthsG1performancewas
S.Berninietal./CognitivetraininginParkinson’Sdisease 11
significantly better than the baseline in global comparableglobalcognitivetestsandlongerfollow-
cognitive functioning measured by MoCA and in upintervalsareneeded.
several executive and non–executive test. As PD Moreover, some studies explored the interplay
is a chronic progressive disease, the worsening between motor and cognitive aspects in PD reha-
observedinG2canbeinterpretedasacognitivepro- bilitation. For example, a study suggested that
file modification due to natural disease evolution, rehabilitativeapproachesinvolvingcognitionappear
while G1 showed a better evolution of cogni- tobethemosteffectiveandpermittoachievemotor
tive decline, probably as a result of the cognitive benefits(Ferrazzolietal.,2018).Otherstudiessug-
intervention. gestedthatthecombinationofphysficalactivityand
Moreover, we can observe that, even if CoRe cognitive exercises may improve cognitive function
o
focused on executive functions, the post-training (memoryandexecutivefunctions)inMCI(Teixeira
effectsobservedinourpatientsseemtobetransferred etal.,2012).Asystematicreview(Murray,Sacheli,
o
also into untrained domains, such as memory, thus Eng,&Stoessl,2014)suggestedthatphysicalexer-
suggesting the presence of a generalization effect. cise improved not only motor symptoms, but also
Infact,assuggestedbyMoroandcolleagues(Moro cognitiveimpairmrentsinPD;buttheextenttowhich
et al., 2015), a training concerning cognitive strate- physical exercise specifically impacts cognition in
P
gies (e.g. task planning, inhibition of interference, PD,andhow,isunclear.Inourstudy,comparingthe
and divided attention) seems to have some impact UPDRSIIIscoresbetweenthebaselineandtheendof
ontheorganizationoftheinformationthatapatient physi calrehabilitationprogram,bothgroupssignifi-
mustremember,withapositivesecondaryeffecton cantlyimprovedandthesizeofthisimprovementwas
d
memory. similar;sowecanconcludethatnosignificanteffect
In order to have a global measure of cognitive ofCTonmotorperformancewasobserved.Further-
e
functioningweusedbothMMSEandMoCA.While more, in our study only patients who also received
the former is the most commonly used test in the CT showed a better evolution of cognitive decline,
literature, it is known that the latter is moretsen- whilepatientswhoreceivedmotorrehabilitationonly
sitive and adequate to investigate logical-ecxecutive tendedtogetworseovertime.Therefore,ourresults
dysfunctionsinPD(Burdicketal.,2014;Dalrymple- donotallowtohypothesizethepresenceofcorrela-
Alfordetal.,2010).Asamatteroffaect,inourstudy tionbetweenmotorandcognitiveperformances.
weobservedachangeinMOCAbutnotinMMSE. Inconclusion,CoReseemstobeaneffectivetreat-
Infact,comparingthebaselinewiththepost-training mentinPD-MCIintheattemptofbrieflystabilizing
r
assessments, within G1 the global cognitive func- cognitivedecline,delayingthedownwardtrajectory
tioningmeasuredbyMoCrAsignificantlyimproved, assuggestedbyWalton(Waltonetal.,2017).
asopposedtothedeclineinthecontrolgroup.This Weareawarethatthisstudyhassomelimitations.
o
improvementwasmoreconsistentimmediatelyafter First of all, we were not able to analyze the num-
theendofthetraininganddecreasedovertime,but berofpatients(alsobecauseofdrop-outs)calculated
C
evenaftersevenmonthstheperformancewashigher fromthesamplesizeestimation.Thus,thestatistical
than the baseline. Furthermore, the percentage of power of the study slightly decreased. On the other
patientsthatimproved,remainedstable,orworsened hand,ourstudyisaprospective,open-unblindedRCT
atMoCAbetweenthebaselineandthenextevalua- performedonahomogeneoussampleandwebelieve
tions, was significantly different in the two groups: thatthesecharacteristicsbalancetherelativelysmall
in G1 most patients improved their global cogni- samplesize.
tivelevel,whileinG2mostpatientsmaintainedtheir The follow-up interval was limited to 6 months;
globalcognitivelevelbetweenT0andT1andwors- however,todatefewRCTspublishedfollow-updata
enedbetweenT0andT2. of CT intervention in PD (Leung et al., 2015) and
A comparison of our results with the literature is onlyonewithalonger(12months)follow-up(Petrelli
difficult because, to date, few studies used a global et al., 2015). Therefore, the present data provide a
measure of cognitive functioning in the analysis of solid stepping stone for future RCTs and appear to
CT effects. Par´ıs (Par´ıs et al., 2011) did not find be largely confirmatory that CT is safe and mod-
significant effects on overall cognitive functions, estly effective on cognition in patients with PD as
measuredbyACEandMMSE,whilePetrelli(Petrelli alsosuggestedbyLeungetal(Leungatal.,2015).
etal.,2015)reportedlong-termeffectafteroneyear Itshouldalsobeclarifiedthatthegoalofthisstudy
using MMSE and Dem Tect. Further RCTs with is not to demonstrate that computerized cognitive
12 S.Berninietal./CognitivetraininginParkinson’Sdisease
training with CoRe is better than traditional paper Appollonio, I., Leone, M., Isella, V., Piamarta, F., Consoli, T.,
andpencilcognitivetraining.Ourresults,inaddition Villa,M.L.,...,&Nichelli,P.(2005).TheFrontalAssess-
toconfirmingthatcognitivetrainingishelpfulinPD, mentBattery(FAB):NormativevaluesinanItalianpopulation
sample.NeurologicalSciences,26(2),108-116.
allowtosuggestthat,inthehospitalsetting,theuseof
Beck,A.T.,Steer,R.A.,&Brown,G.K.(2010).BDI-II,Beck
acomputerisedversionoftheexercisesoffersbene-
DepressionInventory-II.USA,NCSPerson,Inc.,1996(Italian
fits both for the operator and the patient: first, the translation:Ghisi,M.,Flebus,G.B.,Montano,A.,Sanavio,E.,
possibility for an operator to follow more patients Sica,C.Manuale.Adattamentoitaliano.Florence,GiuntiO.S.
simultaneously,withconsequentsavingintimeand OrganizzazioniSpeciali,2010).
Benjamini,Y.,&Yekutieli,D.(2001).Thecontrolofthefalsedis-
costs; second, the availability of all the data, stored f
coveryrateinmultipletestingunderdependency.TheAnnals
inelectronicformat,relatedtotherehabilitationses-
ofStatistics,29(4),1165–1188. o
sions,whichallowtoperformsoundstatisticsbothat Binetti,G.,Moretti,D.V.,Scalvini,C.,Giovanni,G.,Verzeletti,
individualandaggregatedlevel;third,thepossibility C., Mazzini, F., ..., & Benussi, L. (2013). Predictors of
for the patients to continue the treatment even after
comprehensivestimulationoprogramefficacyinpatientswith
cognitive impairment. Clinical practice recommendations.
discharge.
International Journal of Geriatric Psychiatry, 28(1), 26-33.
Inthelightofanapproachcharacterizedbycom- r
doi:10.1002/gps.3785
binationtreatmentsforneurodegenerativedisorders, Burdick,D.J.,CPholerton,B.,Watson,G.S.,Siderowf,A.,Tro-
our data suggest that CoRe could be incorpo- janowski,J.Q.,Weintraub,D.,...,&Leverenz,J.B.(2014).
rated into clinical routine and recommended as a PeoplewithParkinson’sdiseaseandnormalMMSEscorehave
abroadrangeofcognitiveperformance.MovementDisorders,
non-pharmacological complementary therapy, to be
29(10),1258-1264.doi:10.1002/mds.25924
implemented also at home in order to maintain its
Cadffarra,P.,Vezzadini,G.,Dieci,F.,Zonato,F.,&Venneri,A.
benefitsovertime(Allonietal.,2018).Coreiscur- (2002).Rey-Osterriethcomplexfigure:Normativevaluesin
rently a research tool, open for sharing experiences an Italian population sample. Neurological Sciences, 22(6),
with other health professionals. Our next step is to e 443-447.
Carlesimo,C.A.,Caltagirone,C.,Gainotto,G.,&Nocentini,U.
useitasatelerehabilitationtool,fortheprovisionof
(1995). Batteria per la valutazione del deterioramento
remoterehabilitationtreatmentstohome-patientts.
mentale: Standardizzazione e affidabilita´ diagnostica
c nell’identificazione di pazienti affetti da sindrome demen-
ziale.ArchiviodiPsicologia.NeurologiaePsichiatria,56(4),
471-488.
Conflictofinterest e
Caviness,J.N.,Driver-Dunckley,E.,Connor,D.J.,Sabbagh,M.
N.,Hentz,J.G.,Noble,B.,...,&Adler,C.H.(2007).Defining
The authors declare that th rey have no conflict of mildcognitiveimpairmentinParkinson’sdisease.Movement
interest. Disorders,22(9),1272-1277.
r Coyle,H.,Traynor,V.,&Solowij,N.(2015).Computerizedand
virtual reality cognitive training for individuals at high risk
o
ofcognitivedecline:Systematicreviewoftheliterature.The
References
American Journal of Geriatric Psychiatry, 23(4), 335-359.
doi:10.1016/j.jagp.2014.04.009
C
Alloni, A., Quaglini, S., Panzarasa, S., Sinforiani, E., & Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Liv-
Bernini, S. (2018). Evaluation of an ontology-based ingston,L.,Graham,C.,Crucian,G.P.,...,&Anderson,T.J.
system for computerized cognitive rehabilitation. Interna- (2010).TheMoCAwell-suitedscreenforcognitiveimpair-
tional Journal of Medical Informatics, 115, 64-72. doi: ment in Parkinson disease. Neurology, 75(19), 1717-1725.
https://doi.org/10.1016/j.ijmedinf.2018.04.005 doi:10.1212/WNL.0b013e3181fc29c9
Alloni, A., Sinforiani, E., Zucchella, C., Sandrini, G., Bernini, Emre, M., Ford, P. J., Bilgic¸, B., & Uc¸, E. Y. (2014). Cogni-
S., Cattani, B., ... & Pistarini, C. (2017). Computer-based tiveimpairmentanddementiainParkinson’sdisease:Practical
cognitiverehabilitation:theCoResystem.Disabilityandreha- issuesandmanagement.MovementDisorders,29(5),663-672.
bilitation,39(4),407-417. doi:10.1002/mds.25870.
Amato,M.P.,Portaccio,E.,Goretti,B.,Zipoli,V.,Ricchiuti,L., Fahn,S.R.L.E.(1987).UnifiedParkinson’sdiseaseratingscale.
DeCaro,M.F.,...,&Trojano,M.(2006).TheRao’sBrief RecentdevelopmentinParkinson’sdisease.FlorhamPark,NJ:
Repeatable Battery and Stroop Test: Normative values with MacmillanHealthCareInformation,2,153-164.
age,educationandgendercorrectionsinanItalianpopulation. Ferrazzoli, D., Ortelli, P., Madeo, G., Giladi, N., Petzinger, G.
MultipleSclerosisJournal,12(6),787-793. M.,&Frazzitta,G.(2018).BasalGangliaandBeyond:The
Andrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vel- interplaybetweenmotorandcognitiveaspectsinParkinson’s
las, B. (2015). Prevention of sporadic Alzheimer’s disease: disease Rehabilitation. Neuroscience & Biobehavioral
Lessons learned from clinical trials and future directions. Reviews.doi:10.1016/j.neubiorev.2018.05.007
The Lancet Neurology, 14(9), 926-944. doi:10.1016/S1474- Folstein,M.F.,Folstein,S.E.,&McHugh,P.R.(1975).“Mini-
4422(15)00153-2 mentalstate”:A practicalmethodforgradingthecognitive
S.Berninietal./CognitivetraininginParkinson’Sdisease 13
state of patients for the clinician. Journal of Psychiatric executive functions in mild cognitive impairment: Spe-
Research,12(3),189-198. cific efficacy and impact in memory. American Journal of
Giovagnoli,A.R.,DelPesce,M.,Mascheroni,S.,Simoncelli,M., Alzheimer’s Disease & Other Dementias, 30(2), 153-164.
Laiacona,M.,&Capitani,E.(1996).Trailmakingtest:Norma- doi:10.1177/1533317514539542
tivevaluesfrom287normaladultcontrols.TheItalianJournal Murray,D.K.,Sacheli,M.A.,Eng,J.J.,&Stoessl,A.J.(2014).
ofNeurologicalSciences,17(4),305-309. TheeffectsofexerciseoncognitioninParkinson’sdisease:A
Hoehn,M.M.,&Yahr,M.D.(1967).Parkinsonismonset,pro- systematicreview.TranslationalNeurodegeneration,3(1),5.
gression,andmortality.Neurology,17,427. Nasreddine, Z. S., Phillips, N. A., Be´dirian, V., Charbon-
Hu,M.T.,Szewczyk-Kro´likowski,K.,Tomlinson,P.,Nithi,K., neau, S., Whitehead, S., Collin, I., & Chertkow, H.
Rolinski,M.,Murray,C.,...,&Ben-Shlomo,Y.(2014).Pre- (2005). The Montreal Cognitive Assessment, MoCA: A
f
dictorsofcognitiveimpairmentinanearlystageParkinson’s brief screening tool for mild cognitive impairment. Jour-
diseasecohort.MovementDisorders,29(3),351-359. nal of the American Geriatrics Soociety, 53(4), 695-699.
Hughes,A.J.,Daniel,S.E.,Kilford,L.,&Lees,A.J.(1992).Accu- doi:10.1111/j.1532-5415.2005.53221.x
racyofclinicaldiagnosisofidiopathicParkinson’sdisease:A Orgeta,V.,McDonald,K.R.,Poliakoff,E.,Hindle,J.V.,Clare,L.,
clinico-pathologicalstudyof100cases.JournalofNeurology, &Leroi,I.(2015).Cognitiveotraininginterventionsfordemen-
Neurosurgery&Psychiatry,55(3),181-184. tiaandmildcognitiveimpairmentinParkinson’sdisease.The
Jenkinson,C.,&Fitzpatrick,R.(2007).Cross-culturalevaluation CochraneLibrary.
r
of the short form 8-item Parkinson’s Disease Questionnaire Par´ıs,A.P.,Saleta,H.G.,DelaCruzCrespoMaraver,M.,Silvestre,
(PDQ-8): Results from America, Canada, Japan, Italy and E.,Freixa,M.PG.,Torrellas,C.P.,&Ferna´ndez,V.L.(2011).
Spain.Parkinsonism&RelatedDisorders,13(1),22-28. Blindrandomizedcontrolledstudyoftheefficacyofcognitive
Laiacona,M.,Inzaghi,M.G.,DeTanti,A.,&Capitani,E.(2000). traininginParkinson’sdisease.MovementDisorders,26(7),
Wisconsin card sorting test: A new global score, with Ital- 1251-1258.doi:10.1002/mds.23688
ian norms, and its relationship with the Weigl sorting test. Petersen,R.C.,Smith,G.E.,Waring,S.C.,Ivnik,R.J.,Tanga-
NeurologicalSciences,21(5),279-291. dlos,E.G.,&Kokemen,E.(1999).Mildcognitiveimpairment:
Lampit, A., Hallock, H., & Valenzuela, M. (2014). Computer- Clinicalcharacterizationandoutcome.ArchivesofNeurology,
ized cognitive training in cognitively healthy older adults: 56(3),303-308.
A systematic review and meta-analysis of effect modifiers. ePetrelli,A.,Kaesberg,S.,Barbe,M.T.,Timmermann,L.,Rosen,
PLoS Medicine, 11(11), e1001756. doi: 10.1371/jour- J.B.,Fink,G.R.,...,&Kalbe,E.(2015).Cognitivetrain-
nal.pmed.1001756 ing in Parkinson’s disease reduces cognitive decline in the
t
Lawton,M.P.(1988).Scalestomeasurecompetenceineveryday longterm.EuropeanJournalofNeurology,22(4),640-647.
activities.PsychopharmacolBull,24,609-614. c doi:10.1111/ene.12621
Lawton, M. P., Brody, E. M. (1969). Assessment of older peo- Rojas, G. J., Villar, V., Iturry, M., Harris, P., Serrano, C. M.,
ple:Self-maintainingandinstrumentalactivitiesofdailyliving. Herrera, J. A., & Allegri, R. F. (2013). Efficacy of a cog-
e
Gerontologist,9,179-186. nitive intervention program in patients with mild cognitive
Leonardi,G.,Panzarasa,S.,&Quaglini,S.(2011).Ontology-based impairment. International Psychogeriatrics, 25(5), 825-831.
automatic generation of computrerized cognitive exercises. doi:10.1017/S1041610213000045
StudiesinHealthTechnologyandInformatics,169,779-783. Spinnler,H.(1987).Standardizzazioneetaraturaitalianaditest
Leung,I.H.,Walton,C.C.,Hallrock,H.,Lewis,S.J.,Valenzuela, neuropsicologici.ItalJNeurolSci,6,21-120.
M., & Lampit, A. (2015). Cognitive training in Parkinson Teixeira,C.V.L,Gobbi,L.T.B.,Corazza,D.I.,Stella,F.,Costa,
o
disease:Asystematicreviewandmeta-analysis.Neurology, J.L.,&Gobbi,S.(2012.)Non-pharmacologicalinterventions
85(21),1843-1851.doi:10.1212/WNL.0000000000002145 on cognitive functions in older people with mild cognitive
Litvan,I.,Goldman,J.G.,Tro¨ster,A.I.,Schmand,B.A.,Wein- impairment(MCI).ArchGerontolGeriatr,54,175–180.
C
traub,D.,Petersen,R.C.,...,&Emre,M.(2012).Diagnostic Walton,C.C.,Naismith,S.L.,Lampit,A.,Mowszowski,L.,&
criteriaformildcognitiveimpairmentinParkinson’sdisease: Lewis,S.J.(2017).CognitivetraininginParkinson’sdisease:
MovementDisorderSocietyTaskForceguidelines.Movement A theoretical perspective. Neurorehabilitation and Neural
Disorders,27(3),349-356.doi:10.1002/mds.24893 Repair,31(3),207-2016.doi:10.1177/1545968316680489
Moro, V., Condoleo, M. T., Valbusa, V., Broggio, E., Moretto,
G., & Gambina, G. (2015). Cognitive stimulation of
